These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
36 related articles for article (PubMed ID: 10225853)
21. Production and characterisation of monoclonal antibodies to Brucella melitensis cytosoluble proteins that are able to differentiate antibody responses of infected sheep from Rev. 1 vaccinated sheep. Cloeckaert A; Debbarh HS; Zygmunt MS; Dubray G J Med Microbiol; 1996 Sep; 45(3):206-13. PubMed ID: 8810948 [TBL] [Abstract][Full Text] [Related]
22. Antibiotic treatment induces an increase of the specific antibody levels in Brucella melitensis infected mice. Domingo S; Díaz R; Gamazo C FEMS Immunol Med Microbiol; 1995 Oct; 12(2):91-5. PubMed ID: 8589668 [TBL] [Abstract][Full Text] [Related]
23. Characterization of an 18-kilodalton Brucella cytoplasmic protein which appears to be a serological marker of active infection of both human and bovine brucellosis. Goldbaum FA; Leoni J; Wallach JC; Fossati CA J Clin Microbiol; 1993 Aug; 31(8):2141-5. PubMed ID: 8370742 [TBL] [Abstract][Full Text] [Related]
24. Protective immunity to Brucella ovis in BALB/c mice following recovery from primary infection or immunization with subcellular vaccines. Jiménez de Bagüés MP; Elzer PH; Blasco JM; Marín CM; Gamazo C; Winter AJ Infect Immun; 1994 Feb; 62(2):632-8. PubMed ID: 8300219 [TBL] [Abstract][Full Text] [Related]
25. Characteristics of and risk factors for relapse of brucellosis in humans. Ariza J; Corredoira J; Pallares R; Viladrich PF; Rufi G; Pujol M; Gudiol F Clin Infect Dis; 1995 May; 20(5):1241-9. PubMed ID: 7620005 [TBL] [Abstract][Full Text] [Related]
26. Specific antibodies detected during relapse of human brucellosis. Pellicer T; Ariza J; Foz A; Pallares R; Gudiol F J Infect Dis; 1988 May; 157(5):918-24. PubMed ID: 3361155 [TBL] [Abstract][Full Text] [Related]
27. Changes in IgM and IgG antibody concentrations in brucellosis over time: importance for diagnosis and follow-up. Gazapo E; Gonzalez Lahoz J; Subiza JL; Baquero M; Gil J; de la Concha EG J Infect Dis; 1989 Feb; 159(2):219-25. PubMed ID: 2915152 [TBL] [Abstract][Full Text] [Related]
28. Determination by enzyme-linked immunosorbent assay of immunoglobulin G (IgG), IgM, and IgA to Brucella melitensis major outer membrane proteins and whole-cell heat-killed antigens in sera of patients with brucellosis. Araj GF; Kaufmann AF J Clin Microbiol; 1989 Aug; 27(8):1909-12. PubMed ID: 2768476 [TBL] [Abstract][Full Text] [Related]
29. Differentiation between active and inactive human brucellosis by measuring antiprotein humoral immune responses. Goldbaum FA; Rubbi CP; Wallach JC; Miguel SE; Baldi PC; Fossati CA J Clin Microbiol; 1992 Mar; 30(3):604-7. PubMed ID: 1551977 [TBL] [Abstract][Full Text] [Related]
30. Effect of early antibiotic treatment on the antibody response to cytoplasmic proteins of Brucella melitensis in mice. Bowden RA; Racaro GC; Baldi PC Clin Diagn Lab Immunol; 1999 May; 6(3):440-3. PubMed ID: 10225853 [TBL] [Abstract][Full Text] [Related]
31. Brucella melitensis infection in sheep: present and future. Garin-Bastuji B; Blasco JM; Grayon M; Verger JM Vet Res; 1998; 29(3-4):255-74. PubMed ID: 9689741 [TBL] [Abstract][Full Text] [Related]
32. Brucellosis. Pappas G; Akritidis N; Bosilkovski M; Tsianos E N Engl J Med; 2005 Jun; 352(22):2325-36. PubMed ID: 15930423 [No Abstract] [Full Text] [Related]
33. Micro- and nanoformulations of antibiotics against Brucella. Alavi M; Nokhodchi A Drug Discov Today; 2023 Dec; 28(12):103809. PubMed ID: 37923166 [TBL] [Abstract][Full Text] [Related]